Aoxing Pharmaceutical(OTC) AOXG

Aoxing Pharmaceutical Company, Inc. is a specialized drug manufacturer primarily operating within the People's Republic of China. The company focuses on the research, development, production, and distribution of pharmaceutical products, particularly in narcotics and pain management solutions.

Products and Services

• Zhongtong'an: Herbal capsule for oral and dental discomfort
• Yiqi Qiangshen Granule: Herbal preparation for body strength and blood flow
• Tilidine hydrochloride: Synthetic narcotic analgesic for pain relief

Growth Outlook

• Pipeline includes Oxycodone and Acetaminophen tablets for pain management
• Buprenorphine/Naloxone tablet completed Phase II trials for opioid dependence
• Tilidine/Naloxone compound capsule in Phase II trials for pain treatment

Financial Highlights

• Recent quarterly revenue of $17,212, showing potential for growth
• Trailing twelve months gross profit margin at 88.1%, indicating strong product demand
• Current liabilities of $131,345 against total assets of $125,879, highlighting financial challenges

Aoxing Pharmaceutical Company, Inc. operates in a niche market with a focus on pain management and addiction treatments. The product portfolio includes both established and innovative solutions, catering to a growing demand for effective pain relief options. The company is actively developing new products, which may enhance its market position and revenue potential. Recent financial data indicates a revenue increase in the latest quarter, suggesting a positive trend in sales. The gross profit margin remains robust, reflecting the company's ability to maintain profitability despite operational challenges. However, the current liabilities exceed total assets, which may raise concerns regarding financial stability. Overall, Aoxing Pharmaceutical Company, Inc. presents an intriguing opportunity for investors interested in the pharmaceutical sector, particularly in specialized drug manufacturing. The ongoing development of new products and the existing strong gross profit margin may position the company for future growth.